Market Place
Sourcing Support
FDA Extends Review of Savara`s Molgramostim BLA for aPAP
16 Apr 2026 //
FIRSTWORD PHARMA
FDA Extends Review Period for Savara’s Molgramostim
15 Apr 2026 //
BUSINESSWIRE
Savara To Present New Data at ATS 2026 International Conference
14 Apr 2026 //
BUSINESSWIRE
Savara Reports Fourth Quarter And Year End 2025 Financial Results
13 Mar 2026 //
BUSSINESSWIRE
Savara Provides Regulatory Update On The MOLBREEVI* Development
06 Mar 2026 //
BUSSINESSWIRE
Savara Announce Participation In 2026 Citizens Life Sciences Conf
04 Mar 2026 //
BUSSINESSWIRE
Savara To Participate In Investor Healthcare Conferences
04 Feb 2026 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
16 Jan 2026 //
BUSINESSWIRE
Savara Joins 44th J.P. Morgan Healthcare Conference
17 Dec 2025 //
BUSINESSWIRE
Savara To Participate In Investor Healthcare Conferences
03 Nov 2025 //
BUSINESSWIRE
Savara Completes Public Offering, Raises $149.5M
31 Oct 2025 //
BUSINESSWIRE
Savara Announces Chief Medical Officer (CMO) Transition
17 Oct 2025 //
PHARMIWEB
Savara to Participate in Investor Healthcare Conferences
26 Aug 2025 //
BUSINESSWIRE
Savara to Present Ph 3 IMPALA-2 Molgramostim Data at ERS 2025
18 Aug 2025 //
BUSINESSWIRE
Savara Announces Q2 2025 Financial Results and Business Update
13 Aug 2025 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
18 Jul 2025 //
BUSINESSWIRE
Savara`s Lung Disease Asset Hit with FDA Refuse-To-File Letter
28 May 2025 //
FIERCE PHARMA
Savara Announces New Employment Inducement Grant
23 May 2025 //
BUSINESSWIRE
Savara to Attend Jefferies Global Healthcare Conference
22 May 2025 //
BUSINESSWIRE
Savara to Attend H.C. Wainwright & Co. BioConnect Conference
12 May 2025 //
BUSINESSWIRE
Savara to Participate in Citizens Life Sciences Conference
01 May 2025 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
11 Apr 2025 //
BUSINESSWIRE
Savara to Join Leerink Global Healthcare Conference
03 Mar 2025 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
14 Feb 2025 //
BUSINESSWIRE
Savara Publishes Long-Term Data On Molgramostim In aPAP
30 Jan 2025 //
BUSINESSWIRE
Savara Announces Participation in Upcoming Investor Conferences
29 Jan 2025 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
23 Dec 2024 //
BUSINESSWIRE
Savara to Participate in 43rd J.P. Morgan Healthcare Conference
17 Dec 2024 //
BUSINESSWIRE
Savara Reports Q3 2024 Financial Results & Business Update
12 Nov 2024 //
BUSINESSWIRE
Savara to Present at Guggenheim Healthcare Innovation Conf
04 Nov 2024 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
18 Oct 2024 //
BUSINESSWIRE
Savara`s aPAP Patient Journey Map Accepted For CHEST 2024 Poster
01 Oct 2024 //
BUSINESSWIRE
Savara Announces Expanded Access Program For Molgramostim
27 Sep 2024 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
27 Sep 2024 //
BUSINESSWIRE
Savara Names Braden Parker as Chief Commercial Officer
24 Sep 2024 //
BUSINESSWIRE
Savara to Host Analyst and Investor Webinar on September 30, 2024
23 Sep 2024 //
BUSINESSWIRE
Savara to Present at H.C. Wainwright Global Investment Conference
03 Sep 2024 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
16 Aug 2024 //
BUSINESSWIRE
Savara To Present Phase 3 Data On Molgramostim At 2024 ERS Congress
15 Aug 2024 //
BUSINESSWIRE
Savara Reports Q2 2024 Results And Provides Business Update
12 Aug 2024 //
BUSINESSWIRE
Savara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock
28 Jun 2024 //
BUSINESSWIRE
Savara to Present at the Jefferies Global Healthcare Conference
29 May 2024 //
BUSINESSWIRE
Savara Presents New aPAP Data At ATS 2024
19 May 2024 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
16 May 2024 //
BUSINESSWIRE
Savara Reports First Quarter 2024 Financial Results and Provides Business Update
09 May 2024 //
BUSINESSWIRE
Savara to Present at the Citizens JMP Life Sciences Conference
07 May 2024 //
BUSINESSWIRE
Savara to Present New Data on aPAP at the ATS International Conference 2024
08 Apr 2024 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
22 Mar 2024 //
BUSINESSWIRE
Savara Reports Fourth Quarter/Year-End 2023 Financial Results
07 Mar 2024 //
BUSINESSWIRE
Savara to Present at the Barclays 26th Annual Global Healthcare Conference
06 Mar 2024 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
02 Feb 2024 //
BUSINESSWIRE
Savara Introduces aPAP ClearPath
21 Dec 2023 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
15 Dec 2023 //
BUSINESSWIRE
Savara to Present at the Piper Sandler 35th Annual Healthcare Conference
21 Nov 2023 //
BUSINESSWIRE
Revance Appoints Erica Jordan as Chief Commercial Officer, Aesthetics
08 Nov 2023 //
BUSINESSWIRE
Savara to Present at the Jefferies London Healthcare Conference
08 Nov 2023 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
06 Oct 2023 //
BUSINESSWIRE
Savara to Present at H.C. Wainwright 25th Annual Global Investment Conference
05 Sep 2023 //
BUSINESSWIRE
Savara Reports Second Quarter Financial Results and Provides Business Update
10 Aug 2023 //
BUSINESSWIRE
Savara Announces New Employment Inducement Grant
04 Aug 2023 //
BUSINESSWIRE
